For a medication trial to be successful, researchers need access to high-quality data promptly so they may make informed decisions that will improve patient outcomes. When it comes to managing and gaining actionable data from such platforms, SGA shines.
When managing and evaluating the data from clinical trials, SGA is there to back up the needs of ISPs, consulting firms, and pharmaceutical sector clients. Our services include daily research into trial material, subject management, and data analysis that meets the client's internal standards.
Our clinical trial research services groups gather and maintain research data promptly, accurately, and ethically in compliance with regulatory requirements. Data on pharmaceuticals and medical devices is collected and sorted for our clients as part of clinical trial research. The users of industry databases benefit from our insights,... Read More
Why SGA
Industry Leaders
SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.
12+ Languages
Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.
White Papers
Emergence of Novel Immune - Mediated Therapies
Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...
White Papers
Future Trends and Technological Advances in Vaccine and...
The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...
CASE STUDIES
We strongly believe in equal opportunity for all. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.
